We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

97 hedge funds and large institutions have $310M invested in Pernix Therapeutics Holdings, Inc. in 2014 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

160% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 10

61% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 23

54% more capital invested

Capital invested by funds: $202M → $310M (+$109M)

17% more funds holding

Funds holding: 8397 (+14)

66% less call options, than puts

Call options by funds: $819K | Put options by funds: $2.38M

Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
2.59%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.16%
New
26
Increased
37
Reduced
23
Closed
10
Calls
$819K
Puts
$2.38M
Net Calls
-$1.56M
Net Calls Change
-$540K
Name Holding Trade Value Shares
Change
Change in
Stake
ARTA
51
A.R.T. Advisors
New York
$653K +$664K +6,964 New
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$579K +$2.48K +26 +0.4%
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$495K +$298K +3,125 +123%
Charles Schwab
54
Charles Schwab
California
$459K
TA
55
Teachers Advisors
New York
$438K +$4.2K +44 +1%
Goldman Sachs
56
Goldman Sachs
New York
$408K -$1.15M -12,108 -74%
AllianceBernstein
57
AllianceBernstein
Tennessee
$359K +$118K +1,235 +48%
CSS
58
Cubist Systematic Strategies
Connecticut
$344K +$349K +3,663 New
PCM
59
Prelude Capital Management
New York
$320K -$60.1K -630 -16%
UBS Group
60
UBS Group
Switzerland
$310K +$315K +3,300 New
ProShare Advisors
61
ProShare Advisors
Maryland
$305K +$184K +1,929 +146%
BCM
62
Bridgeway Capital Management
Texas
$275K +$30.5K +320 +12%
NFA
63
Nationwide Fund Advisors
Ohio
$258K -$5.15K -54 -2%
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
$253K
RhumbLine Advisers
65
RhumbLine Advisers
Massachusetts
$246K +$7.63K +80 +3%
PPA
66
Parametric Portfolio Associates
Washington
$231K -$12.2K -128 -5%
VOYA Investment Management
67
VOYA Investment Management
Georgia
$225K
US Bancorp
68
US Bancorp
Minnesota
$215K +$40.3K +422 +23%
PAM
69
Panagora Asset Management
Massachusetts
$211K -$252K -2,647 -54%
VKH
70
Virtu KCG Holdings
New York
$200K +$203K +2,128 New
AIG
71
American International Group
New York
$196K -$7.82K -82 -4%
Morgan Stanley
72
Morgan Stanley
New York
$189K +$44.4K +465 +30%
MC
73
Menta Capital
California
$160K +$162K +1,700 New
BA
74
BlackRock Advisors
Delaware
$157K -$9.63K -101 -6%
NV
75
Nair Vinay
$142K +$145K +1,517 New

PTX Hedge Fund Activity: Q4 2014 in Review

97 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q4 2014, worth a combined $310M — up 54% from $202M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PTX positions and 10 closed out — a net gain of 16 holders — while 37 added to existing stakes and 23 trimmed.

The largest buyer was Kennedy Capital Management, adding an estimated $9.39M. The largest seller was Bank of Montreal, cutting an estimated $4.54M.

  • 97 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q4 2014, up from 83 in Q3 2014.
  • Funds reported $310M of Pernix Therapeutics Holdings, Inc. stock for Q4 2014, up 54% quarter-over-quarter.
  • 26 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q4 2014 and 10 closed out, a net change of +16 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q4 2014 was Kennedy Capital Management, an estimated $9.39M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q4 2014 was Bank of Montreal, an estimated $4.54M sold.

Based on aggregated 13F filings for Q4 2014.